Volume | 4,409 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
Advisorshares Pure Us Cannabis Etf | MSOS | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
8.57 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
46 | 4,409 | - | 4.78 - 10.955 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
08:51:33 | 20 | 8.60 | USD |
Advisorshares Pure Us Ca... (MSOS) Options Flow Summary
Advisorshares Pure Us Cannabis Etf Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
999.31M | - | - | - | 12.38 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Advisorshares Pure Us Ca...
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
MSOS Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.74 | 9.59 | 8.44 | 9.08 | 8,735,242 | -0.11 | -1.26% |
1 Month | 9.09 | 10.955 | 8.44 | 9.63 | 10,449,400 | -0.46 | -5.06% |
3 Months | 9.39 | 10.955 | 7.30 | 9.27 | 8,684,180 | -0.76 | -8.09% |
6 Months | 6.60 | 10.955 | 4.92 | 8.27 | 7,258,738 | 2.03 | 30.76% |
1 Year | 5.13 | 10.955 | 4.78 | 7.73 | 6,024,870 | 3.50 | 68.23% |
3 Years | 39.73 | 44.14 | 4.78 | 10.71 | 2,968,587 | -31.10 | -78.28% |
5 Years | 24.90 | 55.91 | 4.78 | 12.15 | 2,554,855 | -16.27 | -65.34% |
The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified. |